|
Genteon and Advanced Chemistry Development Announce GeneManager Software Agreement
|
|
|
San Diego, California and Toronto, Canada, January 14, 2002 - Genteon, Inc.
and Advanced Chemistry Development have signed an agreement whereby ACD will
provide its new ACD/GeneManager software for integration with Genteon's
Capella 400a, a high-throughput 384 capillary electrophoresis system for DNA
polymorphism analysis.
Building on ACD's expertise in the development of spectroscopy and
chromatography software, ACD/GeneManager software was specifically developed
to interpret capillary electrophoresis data. Features include baseline
correction, curve smoothing, mobility shift correction, peak height
normalization, multi-component analysis, peak picking, and sample tracking.
Special versions based on Genteon's internal standards have been developed
for SNP analysis and DNA fragment length analysis with the Capella 400.
Advanced Chemistry Development, Inc. is a leader in the field of physical
property prediction, desktop chromatography and spectroscopy management,
systematic naming, and Web-based access to chemistry prediction. Founded in
1993 and with headquarters in Toronto, Canada, the company employs over 100
people and has established worldwide distribution channels. ACD's mission is
to define a new standard in capability for chemistry-based software,
addressing the needs of spectroscopy, chromatography, global solutions for
analytical data management, physical property prediction, and chemical
naming. Information on the company and its products can be found at
www.acdlabs.com.
Genteon, Inc., founded in 2000, is headquartered in San Diego, CA and is
engaged in the development, manufacturing, and commercialization of
high-performance scientific instruments. The Company's first product, the
Capella 400, is a very high throughput capillary electrophoresis system
designed to speed the discovery and reduce the cost of studying genetic
variations. Genteon's team of engineers and molecular biologists with
extensive experience in genomics is ready to provide its clients with
optimal solutions for their high-throughput DNA analysis needs.
Contacts:
Genteon
Audrey D. Keane - President & CEO
Tel: 858-550-8885
Advanced Chemistry Development
Antony Williams - Vice President, Scientific Development & Marketing
Tel: 416-368-3435
ACD-Genteon Partnership
|
